These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-003975-35 Multi-center, double-blind, placebo-controlled, randomized phase III study to prove the efficacy, safety and tolerability of Lavender oil WS 1265 (Lavandula angustifolia) in patients with restlessness... 2006-06-23 due-trials
Reported results 2005-003747-31 Randomised, Double-Blind, Placebo-Controlled, Parallel Group Trial to Confirm the Efficacy, Safety and Tolerability of Ginkgo biloba Special Extract EGb 761® in Patients Suffering from Mild Mental Imp... 2007-02-14 due-trials
Completed, but no date, and reported results 2005-004474-25 Multi-center, double-blind, placebo-controlled, randomized dose-finding study on Lavender oil WS 1265 (Lavandula angustifolia) in patients with generalized anxiety disorder bad-data
Reported results 2005-004476-20 Randomisierte, doppelblinde, placebokontrollierte Studie im Parallelgruppen-Design zur Untersuchung der Wirkung von Ginkgo-Spezialextrakt EGb 761® auf Lernprozesse bei gesunden Probanden 2006-03-11 due-trials
Reported results 2005-005624-13 Investigation on treatment effect and safety of Hametum® Wund- und Heilsalbe in patients with drug induced skin symptoms. An open phase IV trial [Untersuchung zu Behandlungseffekt und Verträglichkeit... 2006-11-20 due-trials
Completed, but no date, and reported results 2005-005765-11 Randomised, double-blind, placebo-controlled, parallel group trial to confirm the efficacy, safety and tolerability of Ginkgo biloba Special Extract EGb 761® in patients suffering from Mild Mental Imp... bad-data
Reported results 2006-000521-61 Multi-center, double-blind, randomized, reference-controlled study to prove the efficacy, safety and tolerability of Lavender oil WS 1265 (Lavandula angustifolia) in patients with generalized anxiety ... 2011-04-13 due-trials
Reported results 2006-000525-60 Multi-center, double-blind, placebo-controlled, randomized phase III study to demonstrate the efficacy and investigate the safety of Hypericum extract WS® 5570 in patients with a Major Depressive Epis... 2008-03-27 due-trials
Reported results 2006-001756-13 Multi-center, double-blind, placebo-controlled, four-arm, randomized phase II dose finding study with Sokatin® (WS® 1261) in patients with a Major Depressive Episode 2007-09-10 due-trials
Reported results 2006-004523-11 Klinische Studie zur Untersuchung der Wirkung von Weißdorn-Extrakt WS® 1442 auf die Lebensqualität von Patienten mit Herzinsuffizienz NYHA II, die ein moderates Ausdauertraining absolvieren Eine monoz... 2007-09-04 due-trials
Reported results 2007-004923-39 Efficacy and tolerability of EPs 7630 solution in patients (> = 18 years old) with Acute Rhinopharyngitis (ARP) 2010-07-13 due-trials
Completed, but no date, and reported results 2007-005579-33 Efficacy and tolerability of EPs® 7630 solution in patients (>=18 years old) with Acute Rhinopharyngitis (ARP) bad-data
Ongoing 2007-005797-31 Efficacy and tolerability of EPs® 7630 film-coated tablets in patients (>=18 years old) with Acute Rhinopharyngitis (ARP) not-yet-due
Reported results 2008-002134-29 Rhodiola rosea Extract WS® 1375 in Subjects with Life Stress Symptoms 2009-09-23 due-trials
Reported results 2009-015005-39 Monocentric prospective randomized controlled open phase IV study to explorate the mechanismen of the synergetic effect of the Crateagus -Extract WS® 1442 in addition to endurance training related to ... 2011-06-27 due-trials
Reported results 2010-022114-12 Multizentrische prospektive randomisierte kontrollierte offene Phase IV Studie zur Evaluation von Synergien zwischen WS® 1070 und strukturiertem Stressmanagement bei Patienten mit nachlassender Leistu... 2011-07-19 due-trials
Reported results 2010-022441-21 EPs® 7630 film-coated tablets in subjects (≥18 years old) suffering from common cold 2013-08-22 due-trials
Reported results 2010-022686-10 Multi-centre, open-label clinical trial to evaluate the efficacy and safety of Rhodiola rosea extract WS® 1375 2015-01-31 due-trials
Reported results 2011-002652-14 Safety and tolerability of Pelargonium sidoides extract EPs®7630 in children (1 to 5 years old) suffering from acute bronchitis 2013-03-25 due-trials
Reported results 2011-004697-28 Randomised, double-blind trial to compare the treatment effects of Ginkgo biloba extract EGb 761® and pentoxifylline in patients with sub-chronic and chronic tinnitus focussing on psycho-social proble... 2014-04-09 due-trials
Reported results 2012-000438-21 Multi-center, double-blind, placebo-controlled, randomized phase III study to prove the efficacy, safety and tolerability of Silexan (WS®1265) in patients with mixed anxiety and depressive disorder (I... 2014-07-08 due-trials
Completed, but no date, and reported results 2013-000614-38 Monocenter, prospective, randomized placebo-controlled, double blind phase II trial to evaluate protective effects of Gingko biloba extract EGb 761® on temporary hearing damage caused by noise. bad-data
Reported results 2013-004977-28 Safety and intake effect of EPs®7630 (an extract from the roots of Pelargonium sidoides) 2016-08-31 due-trials
Completed, report not yet due 2014-000303-28 Multi-center, prospective, controlled, randomized, single-blinded study to evaluate the efficacy of vibrotactile neuro-feedback additionally to intake of Ginkgo biloba special extract EGb 761® for the... 2018-06-19 not-yet-due
Ongoing 2014-001319-38 Monocenter prospective open singel-arm phase IV study of the effects of hawthorn extract WS® 1442 on arterial micro-vascular structure and macro-vascular function, persistance and erectile function o... not-yet-due
Completed, report not yet due 2014-004702-14 Efficacy and Tolerability of Menthacarin in Patients (≥ 18 years old) suffering from symptoms of Irritable Bowel Syndrome (IBS) 2018-06-15 not-yet-due
Not reported 2015-001101-14 Driving fitness under acute and subchronic application of Silexan® (WS® 1265) in comparison to placebo and Lorazepam with healthy volunteers in two successive, randomized, double-blind, crossover desi... 2017-08-11 due-trials
Completed, but no date 2015-003265-29 Proof of concept trial to evaluate the effectiveness of combined treatment with Valerian extract (Euvegal®) and Lavender oil (Lasea®) in patients suffering from inability to fall or stay asleep bad-data
Not reported 2016-000315-32 Clinical Trial to Explore Treatment Effects of Ginkgo biloba Extract EGb 761® in Patients with Chronic Tinnitus and Effect Modification by Etiology, Biological Factors and Concomitant Pathologies. 2017-12-19 due-trials
Completed, report not yet due 2016-000316-15 Clinical Trial to Explore Treatment Effects of Ginkgo biloba Extract EGb 761® in Patients with Different Types of Vertigo and Effect Modification by Type of Vertigo, Chronicity and Concomitant Patholo... 2018-06-12 not-yet-due